<?xml version="1.0" encoding="UTF-8"?>
<p>We will screen patients who meet the criteria through pre-hospital recruitment and in-hospital inpatients. 192 patients will be included in this study. Patients will randomly select any number from 001 to 192 from a sealed envelope and are assigned to the probiotic group (group A) and placebo group (group B) according to the parity of the number. Probiotics and placebo are marked "A” and "B” respectively. The probiotics are Live Combined Bifidobacterium, Lactobacillus and Enterococcus Powder (Shanghai Xinyi Pharmaceutical Co. Ltd. National drug license S10970105, 1 g/bag), made up of Bifidobacterium, Lactobacillus acidophilus, Enterococcus faecalis. The number of living bacteria per gram is not less than 1.0 × 107CFU. The placebo is made of starch, and there is no difference in appearance and smell between them.</p>
